| Attribute |
Value |
Sources |
| Symbol |
FGF13 |
|
| Name |
Fibroblast Growth Factor 13 |
|
| Chromosome |
Xq26.3 |
|
| NCBI Gene ID |
2253 |
|
| UniProt ID |
P15532 |
|
| Gene Type |
Protein coding |
|
| Alternative Names |
FGF13, FHF-1, FGF13A |
|
FGF13 (Fibroblast Growth Factor 13) is a member of the FGF family that is predominantly expressed in neuronal tissues, distinguishing it from many other FGFs with broader expression patterns. As a non-secretory FGF, FGF13 functions intracellularly to regulate neuronal development, synaptic function, and neuroprotection [@f gf13-neuron].
Unlike classical FGFs that act through receptor tyrosine kinases (FGFRs) at the cell surface, FGF13 localizes to the nucleus and cytoplasm where it interacts with intracellular targets including voltage-gated sodium channels, microtubules, and nuclear proteins. This unique intracellular mode of action makes FGF13 particularly relevant to neuronal function and dysfunction in neurodegenerative diseases [@f gf-family-nd].
The X-linked localization of FGF13 is significant, as mutations in this gene are associated with neurodevelopmental disorders including X-linked intellectual disability and epilepsy, indicating its crucial role in brain function [@f gf13-mutations].
FGF13 operates through distinct mechanisms from secreted FGFs:
1. Sodium Channel Interaction
- FGF13 binds to voltage-gated sodium channels (NaV1.1, NaV1.2, NaV1.6)
- Modulates channel gating and localization
- Regulates neuronal excitability and action potential propagation
2. Nuclear Functions
- Localizes to the nucleus in developing neurons
- May regulate gene expression directly
- Influences cell cycle and differentiation
3. Cytoskeletal Interactions
- Binds to microtubules
- Affects neuronal morphology
- Participates in axon guidance
4. Protein-Protein Interactions
- Interacts with neuronal scaffolding proteins
- Associates with signaling molecules
- Forms complexes with ion channels
FGF13 exhibits neurotrophic effects through both FGFR-dependent and independent mechanisms:
| Mechanism |
Effect |
Relevance to Neurodegeneration |
| FGFR activation |
Neuronal survival signaling |
Protective in AD/PD |
| NaV modulation |
Excitability regulation |
Prevents hyperexcitability |
| Nuclear localization |
Gene expression |
Affects survival pathways |
| Microtubule binding |
Axonal stability |
Protects connectivity |
FGF13 is implicated in multiple aspects of AD pathogenesis [@f gf-ad]:
1. Synaptic Dysfunction
FGF13 localizes to synapses where it:
- Regulates synaptic protein synthesis
- Modulates synaptic plasticity
- Influences memory formation
- Loss of FGF13 contributes to synaptic failure in AD
2. Neurotrophic Signaling Deficit
The neurotrophic support hypothesis of AD posits that:
- Declining neurotrophic factor signaling contributes to neuron loss
- FGF13 provides neuroprotective signals
- Reduced FGF13 in AD brains exacerbates neurodegeneration
3. Excitotoxicity
FGF13's interaction with sodium channels intersects with excitotoxicity:
- Excessive glutamate release is a feature of AD
- Sodium channel dysregulation contributes to calcium influx
- FGF13 modulation of sodium channels may be protective
4. Neurogenesis Impairment
Adult hippocampal neurogenesis is impaired in AD:
- FGF signaling promotes neurogenesis [@f gf-neurogenesis]
- FGF13 decline contributes to reduced neuron replacement
- This impairs hippocampal function and memory
FGF13 contributes to PD through several mechanisms :
1. Dopaminergic Neuron Survival
- FGF13 is expressed in substantia nigra dopaminergic neurons
- Provides trophic support for these vulnerable neurons
- Loss of FGF13 may accelerate dopaminergic degeneration
2. Axonal Integrity
- FGF13 microtubule interactions support axonal transport
- Axonal pathology is an early feature of PD
- FGF13 decline contributes to axonal dysfunction
3. Neuroinflammation
- FGF13 expression is modulated by inflammation
- May participate in glial-neuronal communication
- Chronic inflammation drives neurodegeneration
4. Excitotoxicity in PD
- Excessive neuronal firing occurs in PD
- Sodium channel dysfunction contributes to hyperexcitability
- FGF13's channel-modulating function is neuroprotective
FGF13 dysregulation has been observed in ALS:
- Motor neuron-specific expression patterns
- May contribute to selective vulnerability
- Links to excitotoxicity are particularly relevant
FGF13 expression changes in FTD:
- Altered in tauopathy models
- May contribute to synaptic dysfunction
- Connects to frontotemporal circuit dysfunction
FGF13 shows neuron-specific expression:
- Hippocampus: High expression in CA1-CA3 pyramidal neurons
- Cerebral cortex: Prominent in layers II-III and V
- Cerebellum: Purkinje cells show expression
- Substantia nigra: Dopaminergic neurons
- Spinal cord: Motor neurons
Within neurons, FGF13 localizes to:
- Dendrites and dendritic spines
- Axon initial segments
- Nuclear compartment
- Cytosolic organelles
- NaV1.1 (SCN1A)
- NaV1.2 (SCN2A)
- NaV1.6 (SCN8A)
- Voltage-gated calcium channels
- Beta-tubulin
- Microtubule-associated proteins
- Neuronal scaffolding (PSD-95)
- FGFR1-4 (indirect)
- MAPK pathway components
- PI3K/Akt pathway
FGF13 offers several therapeutic angles for neurodegenerative diseases:
- FGF13 mimics: Develop small molecules that replicate FGF13 signaling
- Gene therapy: Deliver FGF13 to vulnerable neurons
- Sodium channel modulators: Target the FGF13-NaV interaction
- Neurotrophic approaches: Enhance overall neurotrophic support
- Neurogenesis enhancers: Promote neuron replacement
flowchart TD
subgraph FGF13_Expression
A["FGF13 Gene"] --> B["FGF13 Protein"]
B --> C["Neuronal<br/>Expression"]
C --> D["Synapse"]
C --> E["Axon"]
C --> F["Nucleus"]
end
subgraph Normal_Function
D --> G["Synaptic<br/>Plasticity"]
E --> H["Axonal<br/>Stability"]
F --> I["Gene<br/>Regulation"]
G --> J["Memory<br/>Formation"]
H --> K["Signal<br/>Propagation"]
I --> L["Neuronal<br/>Survival"]
end
subgraph Disease_Mechanisms
M["Neurodegeneration"] --> N["FGF13<br/>Downregulation"]
N --> O["Synaptic<br/>Failure"]
N --> P["Axonal<br/>Degeneration"]
N --> Q["Survival<br/>Signal Loss"]
end
subgraph Pathology
O --> R["Alzheimer's<br/>Disease"]
P --> S["Parkinson's<br/>Disease"]
Q --> R
Q --> S
R --> T["Cognitive<br/>Decline"]
S --> U["Motor<br/>Symptoms"]
end
style A fill:#e3f2fd
style M fill:#ffcdd2
style T fill:#b71c1c
style U fill:#b71c1c
- FGF14 — Related neuronal FGF
- FGF2 — Classic neurotrophic FGF
- FGFR1 — FGF receptor